October 2011 Diabetes

Diabetes is becoming a significant burden, both in terms of public health and the economy.

Nicole Wegrzyn uses communication as an advocacy tool.

When insomnia begins to negatively impact a patient's quality of life, pharmacists can explain the nonpharmalogic and pharmalogic treatment options.

This chronic, painful disorder has a complex symptom profile that can make diagnosis and treatment complicated.

A pharmacy benefits manager employee who signed a broadly written contract agreed not to move to a competitor is sued by his former employer.

Two new ventures from the National Associations of Drug Diversion Investigators focus on the prevention of diversion in children and reducing barriers to reporting pharmaceutical crimes.

Knowledge of clinical practice guidelines can protect pharmacists and patients.

The FDA approved Tradjenta (linagliptin) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Sig codes and mnemonics save time behind the counter, but careless mistakes and misinterpretation can lead to serious medication errors.

Recent FDA actions regarding simvastatin mean that pharmacists should refresh their knowledge of this cholesterol-lowering medication.